187 related articles for article (PubMed ID: 30115760)
1. The role of nonmuscle myosin II in polydrug memories and memory reconsolidation.
Briggs SB; Hafenbreidel M; Young EJ; Rumbaugh G; Miller CA
Learn Mem; 2018 Sep; 25(9):391-398. PubMed ID: 30115760
[TBL] [Abstract][Full Text] [Related]
2. Nonmuscle myosin II inhibition disrupts methamphetamine-associated memory in females and adolescents.
Young EJ; Briggs SB; Rumbaugh G; Miller CA
Neurobiol Learn Mem; 2017 Mar; 139():109-116. PubMed ID: 28082169
[TBL] [Abstract][Full Text] [Related]
3. Nonmuscle myosin IIB as a therapeutic target for the prevention of relapse to methamphetamine use.
Young EJ; Blouin AM; Briggs SB; Sillivan SE; Lin L; Cameron MD; Rumbaugh G; Miller CA
Mol Psychiatry; 2016 May; 21(5):615-23. PubMed ID: 26239291
[TBL] [Abstract][Full Text] [Related]
4. Methamphetamine Learning Induces Persistent and Selective Nonmuscle Myosin II-Dependent Spine Motility in the Basolateral Amygdala.
Young EJ; Lin H; Kamenecka TM; Rumbaugh G; Miller CA
J Neurosci; 2020 Mar; 40(13):2695-2707. PubMed ID: 32066582
[TBL] [Abstract][Full Text] [Related]
5. Basolateral amygdala corticotropin releasing factor receptor 2 interacts with nonmuscle myosin II to destabilize memory in males.
Hafenbreidel M; Pandey S; Briggs SB; Arza M; Bonthu S; Fisher C; Tiller A; Hall AB; Reed S; Mayorga N; Lin L; Khan S; Cameron MD; Rumbaugh G; Miller CA
Neurobiol Learn Mem; 2023 Dec; 206():107865. PubMed ID: 37995804
[TBL] [Abstract][Full Text] [Related]
6. Selective, retrieval-independent disruption of methamphetamine-associated memory by actin depolymerization.
Young EJ; Aceti M; Griggs EM; Fuchs RA; Zigmond Z; Rumbaugh G; Miller CA
Biol Psychiatry; 2014 Jan; 75(2):96-104. PubMed ID: 24012327
[TBL] [Abstract][Full Text] [Related]
7. Memory disrupting effects of nonmuscle myosin II inhibition depend on the class of abused drug and brain region.
Briggs SB; Blouin AM; Young EJ; Rumbaugh G; Miller CA
Learn Mem; 2017 Feb; 24(2):70-75. PubMed ID: 28096495
[TBL] [Abstract][Full Text] [Related]
8. Basolateral Amygdala Corticotrophin Releasing Factor Receptor 2 Interacts with Nonmuscle Myosin II to Destabilize Memory.
Hafenbreidel M; Briggs SB; Arza M; Bonthu S; Fisher C; Tiller A; Hall AB; Reed S; Mayorga N; Lin L; Khan S; Cameron MD; Rumbaugh G; Miller CA
bioRxiv; 2023 May; ():. PubMed ID: 37292925
[TBL] [Abstract][Full Text] [Related]
9. Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter.
Cameron KN; Kolanos R; Solis E; Glennon RA; De Felice LJ
Br J Pharmacol; 2013 Apr; 168(7):1750-7. PubMed ID: 23170765
[TBL] [Abstract][Full Text] [Related]
10. Myosin II motor activity in the lateral amygdala is required for fear memory consolidation.
Gavin CF; Rubio MD; Young E; Miller C; Rumbaugh G
Learn Mem; 2012 Jan; 19(1):9-14. PubMed ID: 22174310
[TBL] [Abstract][Full Text] [Related]
11. Hippocampal neurogenesis interferes with extinction and reinstatement of methamphetamine-associated reward memory in mice.
Che X; Bai Y; Cai J; Liu Y; Li Y; Yin M; Xu T; Wu C; Yang J
Neuropharmacology; 2021 Sep; 196():108717. PubMed ID: 34273388
[TBL] [Abstract][Full Text] [Related]
12. Reinstatement of methamphetamine conditioned place preference in nicotine-sensitized rats.
Berry JN; Neugebauer NM; Bardo MT
Behav Brain Res; 2012 Dec; 235(2):158-65. PubMed ID: 22884606
[TBL] [Abstract][Full Text] [Related]
13. Effect of Selective Inhibition of Reactivated Nicotine-Associated Memories With Propranolol on Nicotine Craving.
Xue YX; Deng JH; Chen YY; Zhang LB; Wu P; Huang GD; Luo YX; Bao YP; Wang YM; Shaham Y; Shi J; Lu L
JAMA Psychiatry; 2017 Mar; 74(3):224-232. PubMed ID: 28146250
[TBL] [Abstract][Full Text] [Related]
14. Exogenous SO
Rulan D; Zhenbang Y; Yipu Z; Yuan G; Galaj E; Xiaorui S; Wenshuya L; Jiaqi L; Yan Z; Chang Y; Xi Y; Li S; Yixiao L; Haishui S
Eur J Pharmacol; 2021 Apr; 896():173911. PubMed ID: 33503460
[TBL] [Abstract][Full Text] [Related]
15. Mephedrone interactions with cocaine: prior exposure to the 'bath salt' constituent enhances cocaine-induced locomotor activation in rats.
Gregg RA; Tallarida CS; Reitz AB; Rawls SM
Behav Pharmacol; 2013 Dec; 24(8):684-8. PubMed ID: 24126218
[TBL] [Abstract][Full Text] [Related]
16. Protein synthesis inhibition in the basolateral amygdala following retrieval does not impair expression of morphine-associated conditioned place preference.
Yim AJ; Moraes CR; Ferreira TL; Oliveira MG
Behav Brain Res; 2006 Jul; 171(1):162-9. PubMed ID: 16677727
[TBL] [Abstract][Full Text] [Related]
17. β1-Adrenoceptor in the Central Amygdala Is Required for Unconditioned Stimulus-Induced Drug Memory Reconsolidation.
Zhu H; Zhou Y; Liu Z; Chen X; Li Y; Liu X; Ma L
Int J Neuropsychopharmacol; 2018 Mar; 21(3):267-280. PubMed ID: 29216351
[TBL] [Abstract][Full Text] [Related]
18. The Actin Cytoskeleton as a Therapeutic Target for the Prevention of Relapse to Methamphetamine Use.
Young EJ; Briggs SB; Miller CA
CNS Neurol Disord Drug Targets; 2015; 14(6):731-7. PubMed ID: 26022262
[TBL] [Abstract][Full Text] [Related]
19. Blebbistatin, a novel inhibitor of myosin II ATPase activity, increases aqueous humor outflow facility in perfused enucleated porcine eyes.
Zhang M; Rao PV
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4130-8. PubMed ID: 16249490
[TBL] [Abstract][Full Text] [Related]
20. Cannabidiol disrupts the reconsolidation of contextual drug-associated memories in Wistar rats.
de Carvalho CR; Takahashi RN
Addict Biol; 2017 May; 22(3):742-751. PubMed ID: 26833888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
